Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag crawled time : 13:20 save search
KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA
Published: 2023-06-08 (Crawled : 13:20) - biospace.com/
DAWN 4 | $15.0 -4.76% 680K
|
Professional, Scientific, and T...
|
| O: -0.69%
H: 0.0%
C: -7.55%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 1.26%
H: 1.08%
C: 0.91%
KZIA | $0.379 9.47% 180K
|
Health Technology
|
| O: 1.57%
H: 3.07%
C: 1.53%
paxalisib therapeutics study
Novartis premieres powerful new docuseries at Tribeca Festival to shine a light on debilitating skin disease
Published: 2023-06-08 (Crawled : 13:20) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: -0.62%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 1.26%
H: 1.08%
C: 0.91%
disease novartis skin
Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
Published: 2023-03-07 (Crawled : 13:20) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.12%
H: 0.0%
C: -1.26%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.11%
H: 0.05%
C: -1.21%
meeting novartis
Respiratory Inhalers Market Report 2023-2033
Published: 2023-01-03 (Crawled : 13:20) - prnewswire.com
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.42%
H: 1.35%
C: 1.22%
PHG | $20.0 0.1% 340K
|
Health Technology
|
| O: 3.6%
H: 1.03%
C: 0.71%
ATR | $138.99 -0.09% 83K
|
Process Industries
|
| O: 0.55%
H: 0.44%
C: -0.29%
report respiratory market
Asia Pacific Cancer Gene Therapy Market Report 2022: Advantages of Cancer Gene Therapy Over Conventional Cancer Medicines, as Well as An Increase in Government Backing Driving Expansion
Published: 2022-08-02 (Crawled : 13:20) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -0.0%
H: 0.6%
C: 0.6%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: 0.1%
H: 0.58%
C: -1.18%
SRPT | $114.99 -1.34% 230K
|
Health Technology
|
| O: -0.22%
H: 3.68%
C: 2.91%
GILD | News | $66.33 0.26% 2.8M
|
Health Technology
|
| O: 0.23%
H: 0.97%
C: -0.33%
expansion report therapy cancer market
Global Conjugated Monoclonal Antibodies (mAbs) Market Report 2022: A $12.09 Billion Market by 2026 - Forecast to 2031
Published: 2022-06-17 (Crawled : 13:20) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.74%
H: 0.52%
C: -3.23%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
report market
Global Cytotoxic Drugs Market Estimated to Reach $14,885.2 Million by 2028 and Grow at 1.2% CAGR in the 2021-2028 Timeframe [202-Pages] | Report by Research Dive
Published: 2022-06-13 (Crawled : 13:20) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: -4.56%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: -1.86%
H: 0.0%
C: 0.0%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: 0.0%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: -2.38%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
research report market
Growth: Global Biosimilar Market to Generate $83,836.4 Million and Exhibit a CAGR of 24.9% from 2021 to 2028 [170-Pages] | Report by Research Dive
Published: 2022-05-30 (Crawled : 13:20) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.81 1.34% 1.2M
|
Health Technology
| Email alert
Add to watchlist
research biosimilar report market
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.